Modified Bixuesan significantly alters gene expression related to inflammation and apoptosis in laryngeal cancer cell lines, with notable changes in TP53, CASP3, EGFR, and NF-κB1.
- Open access
Moving in Frontiers in Genetics.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
Modified Bixuesan significantly alters gene expression related to inflammation and apoptosis in laryngeal cancer cell lines, with notable changes in TP53, CASP3, EGFR, and NF-κB1.
Journals this month
Topics moving, week to 23 Oct 2026